69 related articles for article (PubMed ID: 131950)
1. [Exogenous psychosis in a patient with carcinoid syndrome following treatment with p-chlorophenylalanine (PCPA)].
Gruner W
Psychiatr Clin (Basel); 1975; 8(5):266-76. PubMed ID: 131950
[TBL] [Abstract][Full Text] [Related]
2. [The carcinoid syndrome. A case description with special reference to its therapeutic aspects].
Häussinger D; Koch HK; Köttgen E; Fröhlich J; Gerok W
Med Welt; 1982 Aug; 33(34):1155-9. PubMed ID: 6215550
[No Abstract] [Full Text] [Related]
3. [Parachlorophenylalanine and ultrastructure in the carcinoid syndrome].
Rapado A; Oliva H; Traba ML; Díaz Recasens J; Ríuz F; Pérez-Corral F; Farré J; De la Barreda P
Rev Clin Esp; 1974 Jan; 132(1):11-20. PubMed ID: 4276185
[No Abstract] [Full Text] [Related]
4. Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome.
Bax ND; Boulton AJ; Woods HF; Green AR
Postgrad Med J; 1982 Aug; 58(682):493-5. PubMed ID: 6215640
[TBL] [Abstract][Full Text] [Related]
5. [Enzyme activity (monoamine oxidase, histaminase, kallikreinogen) in carcinoids treated with parachlorophenylalanine].
Fanciullacci M; Curradi C; Di Lollo F; Sicuteri F
Boll Soc Ital Biol Sper; 1975 Sep; 51(17):1025-30. PubMed ID: 130150
[No Abstract] [Full Text] [Related]
6. Octreotide treatment of carcinoid hypertensive crisis.
Warner RR; Mani S; Profeta J; Grunstein E
Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
[TBL] [Abstract][Full Text] [Related]
7. [Effects of the administration of somatostatin 14 in the carcinoid syndrome. Clinical and biological study of 2 cases].
Guillard JF; Galmiche JP; Chayvialle JA; Kremer M; Comoy E; Lerebours E; Charbonnel B; Colin R
Gastroenterol Clin Biol; 1983 Dec; 7(12):1016-22. PubMed ID: 6141119
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phenylalanine hydroxylation during treatment of carcinoid syndrome with p-chlorophenylalanine.
Szeinberg A; Shani M; Crispin M; Hirshorn N; Cohen BE; Sheba C
Isr J Med Sci; 1970; 6(4):475-8. PubMed ID: 5472331
[No Abstract] [Full Text] [Related]
9. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].
Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC
Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698
[TBL] [Abstract][Full Text] [Related]
10. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
[TBL] [Abstract][Full Text] [Related]
11. Biochemical assessment of niacin deficiency among carcinoid cancer patients.
Shah GM; Shah RG; Veillette H; Kirkland JB; Pasieka JL; Warner RR
Am J Gastroenterol; 2005 Oct; 100(10):2307-14. PubMed ID: 16181385
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological and therapeutic studies (p-chlorphenylalanin) on carcinoid syndrome in 11 cases].
von Studnitz W; Waldenström J
Klin Wochenschr; 1971 Jul; 49(13):748-55. PubMed ID: 4254559
[No Abstract] [Full Text] [Related]
13. The role of serotonergic mechanisms on amphetamine-induced stereotyped behaviour.
Arushanian EB; Tolpyshev BA
Ann Ist Super Sanita; 1978; 14(1):35-42. PubMed ID: 159010
[TBL] [Abstract][Full Text] [Related]
14. [A case of toxic psychosis caused by bromocriptine].
Jimeno Valdés A; Ruiz Otazo AM; Jimeno Bulnes N
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(6):386-90. PubMed ID: 2698595
[TBL] [Abstract][Full Text] [Related]
15. Metabolic acidosis in patients with the carcinoid syndrome: treatment with parachlorophenylalanine.
Feldman JM
J Surg Oncol; 1982 Apr; 19(4):219-23. PubMed ID: 6176809
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine psychosis.
Perry PJ; Juhl RP
Am J Hosp Pharm; 1977 Aug; 34(8):883-5. PubMed ID: 900138
[TBL] [Abstract][Full Text] [Related]
17. Behavioral alteration in the adult rats prenatally exposed to para-chlorophenylalanine.
Vataeva LA; Kudrin VS; Vershinina EA; Mosin VM; Tiul'kova EI; Otellin VA
Brain Res; 2007 Sep; 1169():9-16. PubMed ID: 17698045
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-biochemical findings in malignant carcinoid during cytostatic therapy (description of a case)].
Vyshinskaia GV; Bassalyk LS; Vasil'ev SA; Gromova NV; Nadezhdina TM
Ter Arkh; 1986; 58(2):129-31. PubMed ID: 3704929
[No Abstract] [Full Text] [Related]
19. [5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine].
Sicuteri F; Anselmi B; Franchi G; Fanciullacci M; Del Bianco PL
Clin Ter; 1972 Jun; 61(6):491-501. PubMed ID: 4273807
[No Abstract] [Full Text] [Related]
20. [Carcinoid tumor--diagnostic and therapeutic problems].
Batowski S; Bielewicz A
Pol Tyg Lek; 1994 Jun 6-13; 49(23-24):536-7. PubMed ID: 7675710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
